Compared with postoperative stereotactic radiation therapy, an investigational intraoperative RT approach could significantly reduce local tumor recurrence and improve survival in patients with newly diagnosed operable brain metastases.
New findings could shift the standard approach to preventing brain metastases in SCLC, particularly as modern MRI allows clinicians to detect and treat brain disease earlier.
The imaging agent could potentially help doctors characterize a malignancy's aggression and identify lesions with a higher likelihood of invasion or metastasis.
A new review led by UCLA researchers examines the utility of commercially available AI tools for screening mammography and evidence surrounding their ability to detect interval cancers.
Scans on these patients show a combination of fibrosis, thickening, honeycombing, cystic changes and dilation of the bronchi, among other imaging features.
Most radiologists log many hours every workday gazing into computer monitors emitting blue light, but their eyes are at close to zero risk of damage from retinal phototoxicity.
A structured program to track incidental findings on body CT has significantly boosted rates of clinician follow-up as well as timely patient adherence to radiologist recommendations for next exams.
While the ACC/AHA 2021 Chest Pain Assessment Guidelines included cardiac CT angiography as a top level recommendation, gaps in evidence still need to be filled.
In the years since the turn of the century, interventional radiology has made quantifiable strides toward familiarizing the general public with the specialty and, along the way, helping IR better compete for business with surgery.
In a study of more than 250 COVID-positive patients with a history of any cancer, fewer than half the cohort had chest CT findings deemed typical for COVID-related pneumonia based on an RSNA classification guide.
New imaging data indicates that the effects of long COVID may begin to dwindle over time, offering hope for those suffering from the long-term ramifications of the virus.
Using risk model-based strategies to determine who should undergo low-dose CT lung cancer screening is more cost effective than current U.S. Preventive Services Task Force guidelines.
